Cargando…
TGFβ3 recruits endogenous mesenchymal stem cells to initiate bone regeneration
BACKGROUND: The recruitment of a sufficient number of endogenous mesenchymal stem cells (MSCs) is the first stage of in-situ tissue regeneration. Transforming growth factor beta-3 (TGFβ3) could recruit stem or progenitor cells and endothelial cells to participate in tissue regeneration. However, the...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681754/ https://www.ncbi.nlm.nih.gov/pubmed/29126441 http://dx.doi.org/10.1186/s13287-017-0693-0 |
_version_ | 1783277972679032832 |
---|---|
author | Deng, Moyuan Mei, Tieniu Hou, Tianyong Luo, Keyu Luo, Fei Yang, Aijun Yu, Bo Pang, Hao Dong, Shiwu Xu, Jianzhong |
author_facet | Deng, Moyuan Mei, Tieniu Hou, Tianyong Luo, Keyu Luo, Fei Yang, Aijun Yu, Bo Pang, Hao Dong, Shiwu Xu, Jianzhong |
author_sort | Deng, Moyuan |
collection | PubMed |
description | BACKGROUND: The recruitment of a sufficient number of endogenous mesenchymal stem cells (MSCs) is the first stage of in-situ tissue regeneration. Transforming growth factor beta-3 (TGFβ3) could recruit stem or progenitor cells and endothelial cells to participate in tissue regeneration. However, the mechanism of TGFβ3 recruiting MSCs toward bone regeneration has remained obscure. METHODS: We estimated the promigratory property of TGFβ3 on human bone marrow MSCs (hBMSCs) cocultured with the vascular cells (human umbilical artery smooth muscle cells or human umbilical vein endothelial cells) or not by Transwell assay. After the addition of the inhibitor (SB431542) or Smad3 siRNA, the levels of MCP1 and SDF1 in coculture medium were tested by ELISA kit, and then the migratory signaling pathway of hBMSCs induced by TGFβ3 was investigated by western blot analysis. In vivo, a 2-mm FVB/N mouse femur defect model was used to evaluate chemokine secretion, endogenous cell homing, and bone regeneration induced by scaffolds loading 1 μg TGFβ3 through qPCR, immunofluorescent staining, immunohistochemical analysis, and Micro-CT, compared to the vehicle group. RESULTS: TGFβ3 (25 ng/ml) directly showed a nearly 40% increase in migrated hBMSCs via the TGFβ signaling pathway, compared to the vehicle treatment. Then, in the coculture system of hBMSCs and vascular cells, TGFβ3 further upregulated nearly 3-fold MCP1 secretion from vascular cells in a Smad3-dependent manner, to indirectly enhance nearly more than 50% of migrated hBMSCs. In vivo, TGFβ3 delivery improved MCP1 expression by nearly 7.9-fold, recruited approximately 2.0-fold CD31(+) vascular cells and 2.0-fold Sca-1(+) PDGFR-α(+) MSCs, and achieved 2.5-fold bone volume fraction (BV/TV) and 2.0-fold bone mineral density, relative to TGFβ3-free delivery. CONCLUSIONS: TGFβ3, as a MSC homing molecule, recruited MSCs to initiate bone formation in the direct-dependent and indirect-dependent mechanisms. This may shed light on the improvement of MSC homing in bone regeneration. |
format | Online Article Text |
id | pubmed-5681754 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-56817542017-11-17 TGFβ3 recruits endogenous mesenchymal stem cells to initiate bone regeneration Deng, Moyuan Mei, Tieniu Hou, Tianyong Luo, Keyu Luo, Fei Yang, Aijun Yu, Bo Pang, Hao Dong, Shiwu Xu, Jianzhong Stem Cell Res Ther Research BACKGROUND: The recruitment of a sufficient number of endogenous mesenchymal stem cells (MSCs) is the first stage of in-situ tissue regeneration. Transforming growth factor beta-3 (TGFβ3) could recruit stem or progenitor cells and endothelial cells to participate in tissue regeneration. However, the mechanism of TGFβ3 recruiting MSCs toward bone regeneration has remained obscure. METHODS: We estimated the promigratory property of TGFβ3 on human bone marrow MSCs (hBMSCs) cocultured with the vascular cells (human umbilical artery smooth muscle cells or human umbilical vein endothelial cells) or not by Transwell assay. After the addition of the inhibitor (SB431542) or Smad3 siRNA, the levels of MCP1 and SDF1 in coculture medium were tested by ELISA kit, and then the migratory signaling pathway of hBMSCs induced by TGFβ3 was investigated by western blot analysis. In vivo, a 2-mm FVB/N mouse femur defect model was used to evaluate chemokine secretion, endogenous cell homing, and bone regeneration induced by scaffolds loading 1 μg TGFβ3 through qPCR, immunofluorescent staining, immunohistochemical analysis, and Micro-CT, compared to the vehicle group. RESULTS: TGFβ3 (25 ng/ml) directly showed a nearly 40% increase in migrated hBMSCs via the TGFβ signaling pathway, compared to the vehicle treatment. Then, in the coculture system of hBMSCs and vascular cells, TGFβ3 further upregulated nearly 3-fold MCP1 secretion from vascular cells in a Smad3-dependent manner, to indirectly enhance nearly more than 50% of migrated hBMSCs. In vivo, TGFβ3 delivery improved MCP1 expression by nearly 7.9-fold, recruited approximately 2.0-fold CD31(+) vascular cells and 2.0-fold Sca-1(+) PDGFR-α(+) MSCs, and achieved 2.5-fold bone volume fraction (BV/TV) and 2.0-fold bone mineral density, relative to TGFβ3-free delivery. CONCLUSIONS: TGFβ3, as a MSC homing molecule, recruited MSCs to initiate bone formation in the direct-dependent and indirect-dependent mechanisms. This may shed light on the improvement of MSC homing in bone regeneration. BioMed Central 2017-11-10 /pmc/articles/PMC5681754/ /pubmed/29126441 http://dx.doi.org/10.1186/s13287-017-0693-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Deng, Moyuan Mei, Tieniu Hou, Tianyong Luo, Keyu Luo, Fei Yang, Aijun Yu, Bo Pang, Hao Dong, Shiwu Xu, Jianzhong TGFβ3 recruits endogenous mesenchymal stem cells to initiate bone regeneration |
title | TGFβ3 recruits endogenous mesenchymal stem cells to initiate bone regeneration |
title_full | TGFβ3 recruits endogenous mesenchymal stem cells to initiate bone regeneration |
title_fullStr | TGFβ3 recruits endogenous mesenchymal stem cells to initiate bone regeneration |
title_full_unstemmed | TGFβ3 recruits endogenous mesenchymal stem cells to initiate bone regeneration |
title_short | TGFβ3 recruits endogenous mesenchymal stem cells to initiate bone regeneration |
title_sort | tgfβ3 recruits endogenous mesenchymal stem cells to initiate bone regeneration |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681754/ https://www.ncbi.nlm.nih.gov/pubmed/29126441 http://dx.doi.org/10.1186/s13287-017-0693-0 |
work_keys_str_mv | AT dengmoyuan tgfb3recruitsendogenousmesenchymalstemcellstoinitiateboneregeneration AT meitieniu tgfb3recruitsendogenousmesenchymalstemcellstoinitiateboneregeneration AT houtianyong tgfb3recruitsendogenousmesenchymalstemcellstoinitiateboneregeneration AT luokeyu tgfb3recruitsendogenousmesenchymalstemcellstoinitiateboneregeneration AT luofei tgfb3recruitsendogenousmesenchymalstemcellstoinitiateboneregeneration AT yangaijun tgfb3recruitsendogenousmesenchymalstemcellstoinitiateboneregeneration AT yubo tgfb3recruitsendogenousmesenchymalstemcellstoinitiateboneregeneration AT panghao tgfb3recruitsendogenousmesenchymalstemcellstoinitiateboneregeneration AT dongshiwu tgfb3recruitsendogenousmesenchymalstemcellstoinitiateboneregeneration AT xujianzhong tgfb3recruitsendogenousmesenchymalstemcellstoinitiateboneregeneration |